Sarclisa Escena Injection, Solution
Product Images NDC 0024-0674

Product Visual Gallery

This gallery contains 44 technical images submitted to the FDA as part of the official labeling for Sarclisa Escena (NDC 0024-0674). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sanofi-aventis U.s. Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (07730e8c 1340 4d30 8d71 E20f850db8da 01)

An illustration showing a close-up view of a device used for delivering Sarclisa Escena subcutaneous injection alongside a labeled vial of Sarclisa Escena isatuximab-irfc 140 mg/mL injection solution. The device features a green and gray design with a logo on the center cap, and the vial has a green cap and label band.*

FDA Label Image

Image (07730e8c 1340 4d30 8d71 E20f850db8da 02)

FDA Label Image

Image (07730e8c 1340 4d30 8d71 E20f850db8da 03)

FDA Label Image

Image (07730e8c 1340 4d30 8d71 E20f850db8da 04)

FDA Label Image

Image (07730e8c 1340 4d30 8d71 E20f850db8da 05)

FDA Label Image

Image (07730e8c 1340 4d30 8d71 E20f850db8da 06)

Sarclisa Escena 140 mg/mL isatuximab-irfc injection, solution in a small clear vial with a green cap and a label displaying the brand name in blue and green text along with a green horizontal stripe. The product is labeled by Sanofi-Aventis U.S. LLC for subcutaneous administration.*

FDA Label Image

Image (07730e8c 1340 4d30 8d71 E20f850db8da 07)

An illustration diagram of the wearable on-body injector for Sarclisa Escena subcutaneous injection, labeled with parts including the green vial port for Sarclisa Escena vial only, filling base, red fill gauge, and gray retainer strap that opens automatically after filling. The device can be removed after filling.*

FDA Label Image

Image (07730e8c 1340 4d30 8d71 E20f850db8da 08)

The image shows a vial labeled Sarclisa Escena containing isatuximab-irfc for subcutaneous injection, solution at 140 mg/mL strength. The vial has a green cap and a green band near the bottom. The labeler is Sanofi-Aventis U.S. LLC.*

FDA Label Image

Image (07730e8c 1340 4d30 8d71 E20f850db8da 09)

An instructional diagram illustrating six steps related to medication preparation or administration. The steps show: (1) a vial, (2) a sterile tray, (3) medication packaging or informational inserts, (4) a pair of gloves, (5) a red sharps disposal container, and (6) a yellow biohazard waste container. This visual likely supports safe handling and disposal procedures for injection medications.*

FDA Label Image

Image (07730e8c 1340 4d30 8d71 E20f850db8da 10)

An instructional illustration showing a hand peeling back the green flip-off cap from the top of a vial containing a liquid solution. The image depicts the first step in preparing an injection vial, relevant to subcutaneous injection products like Sarclisa Escena (isatuximab-irfc) 140 mg/mL solution.*

FDA Label Image

Image (07730e8c 1340 4d30 8d71 E20f850db8da 11)

An instructional illustration showing a gloved hand peeling back a protective cap from the top of a vial containing a solution intended for injection. The image depicts proper vial preparation technique for a subcutaneous injection product.*

FDA Label Image

Image (07730e8c 1340 4d30 8d71 E20f850db8da 12)

An instructional illustration showing a hand lifting a protective seal or lid from a container or medication packaging, indicated by a green curved arrow. The image likely depicts a step in preparing a subcutaneous injection product, such as Sarclisa Escena injection solution, for use.*

FDA Label Image

Image (07730e8c 1340 4d30 8d71 E20f850db8da 13)

An instructional illustration showing a hand holding a capped vial with a green arrow pointing upward to indicate removing the cap from the vial, which is being held by another hand over an open container or tray.*

FDA Label Image

Image (07730e8c 1340 4d30 8d71 E20f850db8da 14)

FDA Label Image

Image (07730e8c 1340 4d30 8d71 E20f850db8da 15)

An instructional illustration showing a close-up of a gloved hand placing or removing a cap onto a vial or container with a green ring, next to a circular device with a green and red marking, likely part of an injection preparation or administration system.*

FDA Label Image

Image (07730e8c 1340 4d30 8d71 E20f850db8da 16)

An instructional illustration showing a hand pressing down on a cap or stopper on a vial or injection device, with a green arrow indicating the direction. An inset image depicts a hand turning or rotating the cap or vial, demonstrating part of the preparation or administration process for the injection solution.*

FDA Label Image

Image (07730e8c 1340 4d30 8d71 E20f850db8da 17)

FDA Label Image

Image (07730e8c 1340 4d30 8d71 E20f850db8da 18)

An instructional illustration showing the proper placement of a subcutaneous injection site on the human abdomen. The green area indicates the recommended location, with a focus on administering the Sarclisa Escena injection.*

FDA Label Image

Image (07730e8c 1340 4d30 8d71 E20f850db8da 19)

FDA Label Image

Image (07730e8c 1340 4d30 8d71 E20f850db8da 20)

FDA Label Image

Image (07730e8c 1340 4d30 8d71 E20f850db8da 21)

FDA Label Image

Image (07730e8c 1340 4d30 8d71 E20f850db8da 22)

FDA Label Image

Image (07730e8c 1340 4d30 8d71 E20f850db8da 23)

An instructional diagram of a drug delivery device showing labeled components including the Fill Window, Red Fill, Gauge, Button, Adhesive Tab, and Red Safety Tab. The diagram highlights important parts for handling or administering the injection.*

FDA Label Image

Image (07730e8c 1340 4d30 8d71 E20f850db8da 24)

An instructional diagram showing the top view of a Sarclisa Escena subcutaneous injection device component. The illustration labels the needle inside the needle cover, cautions not to touch the needle cover, and identifies the white sticky adhesive and a button on the device surface.*

FDA Label Image

Image (07730e8c 1340 4d30 8d71 E20f850db8da 25)

An instructional illustration showing a close-up of a subcutaneous injection device for Sarclisa Escena (isatuximab-irfc) 140 mg/mL. The diagram includes a hand holding a vial and a device component with an arrow indicating a step or motion, likely demonstrating proper preparation or connection of the injection system.*

FDA Label Image

Image (07730e8c 1340 4d30 8d71 E20f850db8da 26)

FDA Label Image

Image (07730e8c 1340 4d30 8d71 E20f850db8da 27)

FDA Label Image

Image (07730e8c 1340 4d30 8d71 E20f850db8da 28)

Instructional diagram showing a hand lifting the clear liner off the cap of a vial or container, indicating the removal step for preparation or use of a subcutaneous injection product.*

FDA Label Image

Image (07730e8c 1340 4d30 8d71 E20f850db8da 29)

FDA Label Image

Image (07730e8c 1340 4d30 8d71 E20f850db8da 30)

An instructional diagram showing the correct positioning of the Sarclisa Escena injection device for subcutaneous administration. The illustration highlights how to hold the device against the skin at the injection site, providing visual guidance for proper use.*

FDA Label Image

Image (07730e8c 1340 4d30 8d71 E20f850db8da 31)

An instructional illustration showing a gloved hand holding a medical device or applicator with three circular openings, each outlined in different colors (green, gray, red). The image appears to demonstrate use or proper handling of a device, possibly related to injection administration.*

FDA Label Image

Image (07730e8c 1340 4d30 8d71 E20f850db8da 32)

An instructional illustration showing hands manipulating a device, likely demonstrating the removal or unlocking mechanism involving rotating or sliding parts indicated by a green arrow and curved lines. It appears to be part of a step-by-step guide for preparing or using a medical injection device.*

FDA Label Image

Image (07730e8c 1340 4d30 8d71 E20f850db8da 33)

Sarclisa Escena 140 mg/mL subcutaneous injection solution label from Sanofi-Aventis U.S. LLC. The label includes the proprietary and generic names, dosage form, strength, and route of administration. Warning symbols are present, indicating caution in handling or use.*

FDA Label Image

Image (07730e8c 1340 4d30 8d71 E20f850db8da 34)

FDA Label Image

Image (07730e8c 1340 4d30 8d71 E20f850db8da 35)

FDA Label Image

Image (07730e8c 1340 4d30 8d71 E20f850db8da 36)

An instructional diagram showing the correct alignment and attachment of parts for subcutaneous injection device setup. The illustration highlights a circular component with colored marks and an arrow indicating the direction for proper connection.*

FDA Label Image

Image (07730e8c 1340 4d30 8d71 E20f850db8da 37)

An instructional diagram showing a dial or knob with red and green colored indicators. The upper part depicts the dial with an arrow pointing counterclockwise and a small hourglass symbol, suggesting a timed or adjustable mechanism. The lower part zooms in on the dial, showing detailed markers and colored zones for adjustment or measurement purposes.*

FDA Label Image

Image (07730e8c 1340 4d30 8d71 E20f850db8da 38)

FDA Label Image

Image (07730e8c 1340 4d30 8d71 E20f850db8da 39)

An instructional diagram showing use of the Sarclisa Escena subcutaneous injection device. It includes an image of the injection apparatus with a timer indicating 20 minutes, and a close-up of the device's cap being removed by pulling in the direction of a green arrow. The images illustrate preparation and use steps for the injection device.*

FDA Label Image

Image (07730e8c 1340 4d30 8d71 E20f850db8da 40)

An illustration showing a close-up of a circular dial or knob with a green curved indicator and a small red mark on its edge, likely representing a control or adjustment mechanism on a medical device or packaging component.*

FDA Label Image

Image (07730e8c 1340 4d30 8d71 E20f850db8da 41)

An instructional illustration showing a gloved hand holding a vial or similar container with a cap, demonstrating a step in the preparation or administration of an injectable product, likely Sarclisa Escena (isatuximab-irfc) subcutaneous injection.*

FDA Label Image

Image (07730e8c 1340 4d30 8d71 E20f850db8da 42)

A symbol table providing standardized medical packaging symbols and their meanings relevant to prescription drugs. Symbols include instructions for use, unique device identifier, storage conditions such as keeping dry and temperature limitation, sterility indicators, batch code, use-by date, prescription requirement, and warnings about reuse and repackaging.*

FDA Label Image

Image (07730e8c 1340 4d30 8d71 E20f850db8da 43)

A label segment showing the words 'STERILE' and the letter 'R' in separate boxed sections, indicating the product is sterile and possibly related to a specific regulation or designation.*

FDA Label Image

Principal Display Panel (140 mg/mL Vial Carton)

Sarclisa Escena (isatuximab-irfc) Injection 1,400 mg/10 mL (140 mg/mL) subcutaneous solution packaging label. The label includes product name, strength, route (subcutaneous), dosage form (injection), NDC 0024-0674, and states for subcutaneous use by healthcare providers only. Labeler is Sanofi-Aventis U.S. LLC. The design features a green and white color scheme with dosage and handling information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.